Literature DB >> 7642966

Cytotrophoblast cells: a barrier to maternofetal transmission of passive immunity.

N A Bright1, C D Ockleford.   

Abstract

The human fetus receives passive immunity via the chorioallantoic placenta in the form of maternal immunoglobulin G (IgG) class antibodies. This provides protection against pathogens at a time when the fetus is immunologically naive. We localized endogenous human IgG using confocal laser scanning fluorescence microscopy and immunoelectron microscopy of frozen sections of chorionic villi from early and late gestation. With confocal microscopy we also investigated the distribution of a receptor for IgG (Fc gamma RIII; CD16) that is typically expressed on the surface of human leukocytes. Endogenous IgG was present in the syncytiotrophoblast that surrounds chorionic villi but underlying cytotrophoblast cells were devoid of endogenous antibody. Fc gamma RIII immunoreactivity was confined to the syncytiotrophoblast and was also absent from cytotrophoblast cells. We propose that cytotrophoblast cells present a barrier to the transmission of maternally derived IgG across the human placenta. This accounts for the paradox that there are low levels of transport in the first trimester when the syncytiotrophoblast is known to express receptors for IgG. Cytotrophoblast cells form an almost complete epithelial layer underlying the syncytiotrophoblast at this stage of gestation, but this becomes discontinuous as the placenta matures, thus removing the cellular impediment to IgG transmission.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642966     DOI: 10.1177/43.9.7642966

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  8 in total

1.  Autoantibodies to folate receptor during pregnancy and neural tube defect risk.

Authors:  Robert M Cabrera; Gary M Shaw; Johnathan L Ballard; Suzan L Carmichael; Wei Yang; Edward J Lammer; Richard H Finnell
Journal:  J Reprod Immunol       Date:  2008-09-18       Impact factor: 4.054

2.  Ultrastructural distribution of endogenous immunoglobulin-G in human term amniochorion.

Authors:  N A Bright; C D Ockleford
Journal:  Cell Tissue Res       Date:  1995-08       Impact factor: 5.249

3.  Expression of placental alkaline phosphatase does not correlate with IgG binding, internalization and transcytosis.

Authors:  I Stefaner; A Stefanescu; W Hunziker; R Fuchs
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

Review 4.  Microbial Vertical Transmission during Human Pregnancy.

Authors:  Nitin Arora; Yoel Sadovsky; Terence S Dermody; Carolyn B Coyne
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

5.  Fab fragment glycosylated IgG may play a central role in placental immune evasion.

Authors:  Jiang Gu; Yu Lei; Yuanping Huang; Yingying Zhao; Jing Li; Tao Huang; Junjun Zhang; Juping Wang; Xiaodong Deng; Zhengshan Chen; Christine Korteweg; Ruishu Deng; Meiling Yan; Qian Xu; Shengnan Dong; Monghong Cai; Lili Luo; Guowei Huang; Yun Wang; Qian Li; Changmei Lin; Meng Su; Chunzhang Yang; Zhengping Zhuang
Journal:  Hum Reprod       Date:  2014-12-11       Impact factor: 6.918

Review 6.  Zika virus - reigniting the TORCH.

Authors:  Carolyn B Coyne; Helen M Lazear
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

7.  Expression of FcRn receptor in placental tissue and its relationship with IgG levels in term and preterm newborns.

Authors:  Natalia A Lozano; Alejandro Lozano; Vanina Marini; Ricardo J Saranz; Richard S Blumberg; Kristi Baker; Maria F Agresta; Marina F Ponzio
Journal:  Am J Reprod Immunol       Date:  2018-05-10       Impact factor: 3.886

8.  The antagonism of folate receptor by dolutegravir: developmental toxicity reduction by supplemental folic acid.

Authors:  Robert M Cabrera; Jaclyn P Souder; John W Steele; Lythou Yeo; Gabriel Tukeman; Daniel A Gorelick; Richard H Finnell
Journal:  AIDS       Date:  2019-11-01       Impact factor: 4.177

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.